Skip to content

Clinical trials

Pathologic Processes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20094
20131
20142
20161
20172
20181
20192
20201
20211
20233
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Terminated3
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated3
Zealand Pharma2
AIRNA Corporation1
Aeris Therapeutics1
AstraZeneca1
Celgene1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Eli Lilly and Company1
GlaxoSmithKline1
Goethe University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes27
Lung Diseases9
Respiratory Tract Diseases9
Cardiovascular Diseases7
Digestive System Diseases5
Genetic Diseases, Inborn5
Heart Diseases5
Fibrosis4
Immune System Diseases4
Infant, Newborn, Diseases4

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.